Transamerica Financial Advisors’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $144K | Sell |
514
-29
| -5% | -$7.62K | 0.01% | 487 |
|
|
2026
Q1 | $145K | Buy |
543
+337
| +164% | +$91.3K | 0.01% | 443 |
|
|
2025
Q4 | $51.7K | Sell |
206
-134
| -39% | -$35.6K | ﹤0.01% | 543 |
|
|
2025
Q3 | $97.5K | Buy |
340
+89
| +35% | +$23.8K | 0.01% | 407 |
|
|
2025
Q2 | $65.7K | Sell |
251
-7
| -3% | -$1.71K | 0.01% | 296 |
|
|
2025
Q1 | $60K | Buy |
258
+1
| +0.4% | +$243 | 0.01% | 299 |
|
|
2024
Q4 | $59K | Buy |
257
+241
| +1,506% | +$55.3K | 0.01% | 305 |
|
|
2024
Q3 | $4K | Sell |
16
-185
| -92% | -$40.7K | ﹤0.01% | 364 |
|
|
2024
Q2 | $41K | Hold |
201
| – | – | ﹤0.01% | 282 |
|
|
2024
Q1 | $44K | Sell |
201
-777
| -79% | -$171K | ﹤0.01% | 306 |
|
|
2023
Q4 | $223K | Sell |
978
-93
| -9% | -$19.5K | 0.03% | 235 |
|
|
2023
Q3 | $216K | Sell |
1,071
-329
| -24% | -$69.4K | 0.03% | 217 |
|
|
2023
Q2 | $291K | Sell |
1,400
-27
| -2% | -$5.24K | 0.04% | 208 |
|
|
2023
Q1 | $282K | Buy |
1,427
+138
| +11% | +$28.4K | 0.04% | 216 |
|
|
2022
Q4 | $261K | Sell |
1,289
-37
| -3% | -$7.23K | 0.04% | 210 |
|
|
2022
Q3 | $234K | Buy |
1,326
+36
| +3% | +$7.37K | 0.03% | 215 |
|
|
2022
Q2 | $260K | Buy |
+1,290
| New | +$275K | 0.04% | 211 |
|
|
2020
Q3 | – | Sell |
-5
| Closed | -$1K | – | 359 |
|
|
2020
Q2 | $1K | Buy |
+5
| New | +$692 | ﹤0.01% | 434 |
|
|
2019
Q3 | – | Sell |
-10
| Closed | -$2K | – | 350 |
|
|
2019
Q2 | $2K | Buy |
+10
| New | +$1.4K | ﹤0.01% | 394 |
|
|
2019
Q1 | – | Sell |
-24
| Closed | -$3K | – | 311 |
|
|
2018
Q4 | $3K | Hold |
24
| – | – | ﹤0.01% | 337 |
|
|
2018
Q3 | $4K | Sell |
24
-21
| -47% | -$3.19K | ﹤0.01% | 345 |
|
|
2018
Q2 | $7K | Sell |
45
-48,292
| -100% | -$7.29M | ﹤0.01% | 270 |
|
|
2018
Q1 | $6.72M | Sell |
48,337
-11,301
| -19% | -$1.66M | 0.99% | 29 |
|
|
2017
Q4 | $8.17M | Sell |
59,638
-866
| -1% | -$114K | 1.08% | 21 |
|
|
2017
Q3 | $7.85M | Sell |
60,504
-2,090
| -3% | -$279K | 0.97% | 22 |
|
|
2017
Q2 | $8.29M | Buy |
62,594
+45,716
| +271% | +$5.6M | 1.12% | 15 |
|
|
2017
Q1 | $2.08M | Buy |
16,878
+27
| +0.2% | +$3.2K | 0.25% | 113 |
|
|
2016
Q4 | $1.86M | Buy |
16,851
+200
| +1% | +$22.2K | 0.22% | 119 |
|
|
2016
Q3 | $1.97M | Buy |
16,651
+1,412
| +9% | +$166K | 0.21% | 116 |
|
|
2016
Q2 | $1.71M | Buy |
15,239
+15,167
| +21,065% | +$1.63M | 0.17% | 121 |
|
|
2016
Q1 | $8K | Sell |
72
-33,991
| -100% | -$3.26M | ﹤0.01% | 573 |
|
|
2015
Q4 | $3.62M | Buy |
34,063
+1,985
| +6% | +$205K | 0.27% | 77 |
|
|
2015
Q3 | $2.99M | Buy |
32,078
+1,048
| +3% | +$108K | 0.24% | 82 |
|
|
2015
Q2 | $3.23M | Buy |
31,030
+2,796
| +10% | +$291K | 0.23% | 88 |
|
|
2015
Q1 | $3.06M | Buy |
28,234
+28,130
| +27,048% | +$2.89M | 0.21% | 91 |
|
|
2014
Q4 | $10K | Buy |
104
+81
| +352% | +$7.16K | ﹤0.01% | 501 |
|
|
2014
Q3 | $2K | Hold |
23
| – | – | ﹤0.01% | 575 |
|
|
2014
Q2 | $2K | Buy |
23
+1
| +5% | +$87 | ﹤0.01% | 587 |
|
|
2014
Q1 | $2K | Sell |
22
-80
| -78% | -$6.38K | ﹤0.01% | 553 |
|
|
2013
Q4 | $9K | Sell |
102
-19,848
| -99% | -$1.69M | ﹤0.01% | 465 |
|
|
2013
Q3 | $1.7M | Buy |
19,950
+6,656
| +50% | +$561K | 0.22% | 61 |
|
|
2013
Q2 | $1.14M | Buy |
+13,294
| New | +$1.1M | 0.19% | 64 |
|
Other funds holding LH
Transamerica Financial Advisors's LH Position: Q2 2026 in Review
Transamerica Financial Advisors reduced its Labcorp (LH) stake by 5.3% in Q2 2026, selling an estimated $7.62K and leaving 514 shares worth $144K. The position accounts for 0.01% of the portfolio, ranked #487.
Transamerica Financial Advisors first reported a position in LH in Q2 2013 and has held it in 42 quarters since. The position peaked at $8.29M in Q2 2017. 1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Transamerica Financial Advisors held 514 shares of Labcorp worth $144K as of Q2 2026.
- Transamerica Financial Advisors sold 29 Labcorp shares in Q2 2026, an estimated $7.62K.
- Labcorp made up 0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #487 holding.
- Transamerica Financial Advisors first reported a position in Labcorp in Q2 2013 and has held it in 42 quarters since.
- Transamerica Financial Advisors's Labcorp position peaked at $8.29M in Q2 2017.
- 1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.